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Abstract Site-directed mutants of yeast ATPase were studied 
after introduction of mutant alíeles into a yeast strain where 
these alíeles were constitutively expressed and the expression of 
the wild-type chromosomal ATPase gene was turned off. One 
objection to this constitutive expression system was made 
apparent recently, as dominant lethal mutations are lost by gene 
conversion with the wild-type alíele during the process. Here, the 
phenotypes of the mutant alíeles, which were studied in a 
constitutive expression system, are re-evaluated under conditions 
in which these site-directed mutants are conditionally expressed. 
We show that 12 of 25 site-directed mutations previously 
described are actually dominant lethal alíeles. In addition, we 
show that dominant mutant proteins interfere with transport of 
wild-type ATPase to the plasma membrane. 
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1. Introduction 
The yeast plasma membrane H + -ATPase from Saccharomy-
ces cerevisiae is an electrogenic proton pump essential for 
nutrient uptake and intracellular p H regulation [1,2]. The 
yeast ATPase belongs to the large family of cation ATPases, 
which forms an aspartyl-phosphate intermediate during catal-
ysis and is vanadate sensitive [3]. 
Site-directed mutagenesis has been used to study s t ructure-
function relationships of the yeast enzyme. This approach has 
allowed the identification of several residues of the enzyme 
essential for catalysis [4—8]. In those studies, the mutan t AT-
Pase gene was constitutively expressed from its own promotor 
in a yeast strain in which the expression of the wild-type 
chromosomal ATPase gene {PMAI) is under control of the 
inducible promotor of the GAL1 gene [9]. To study the mu-
tant ATPases, the cells were switched to glucose-containing 
medium in which the chromosomal wild-type PMAI gene is 
turned off and only the mutan t form is expressed. A drawback 
of this constitutive expression system was pointed out recently 
in the work of Harris et al. [10] and Supply et al. [11]. These 
authors show that since the mutant gene is co-resident in the 
cell with a wild-type gene, a dominant lethal mutat ion can be 
lost during sequence shuffling by gene conversion with either 
PMAI or its unexpressed homologous gene PMA2. In fact, 
the mutan t alíele pmal -D378N, reported to render a function-
al ATPase in a previous study [4], was later shown to be an 
example of gene conversion [12,13]. It is therefore important 
to determine whether any of the other site-directed mutants 
previously studied are in fact dominant lethals. 
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Here, we have investigated the dominant lethality of previ-
ously generated site-directed mutants [4-8]. The phenotype of 
the mutant alíeles was re-evaluated using a galactose-inducible 
expression system. Twelve of 25 mutants exhibited a dominant 
negative phenotype. Immunofluorescence staining of HA-
tagged wild-type P m a l shows that dominant lethal proteins 
hamper the transport of the wild-type ATPase to the plasma 
membrane. 
2. Materials and methods 
2.1. Yeast strains and growth media 
Saccharomyces cerevisiae strain XZ611 is Gal+ MATa. ura3 leu2 
trpl [13] and was used to determine the dominant lethality oí pmal 
genes. Autodiploid W303, obtained from W303-1B (Gal+ MATa 
ade2 ura3 his3 leu2 trpl canl) [14] by transformation with the HO 
gene [15], was used in immunofluorescence experiments. Synthetic 
media with 2% dextrose (SD), 2% lactic acid (SL) or 2% galactose 
(SG) and the appropriate requirements were used [16]. Yeast cells 
were transformed using the lithium acetate procedure [17], and trans-
formants selected in SD medium. To test the dominant lethality of the 
pmal alíeles, transformants were transferred to SL medium and, after 
growth, suspended in water to a cell density of 2 X 107 cell/ml and 5 ul 
were dropped on SG. 
2.2. Plasmids 
The pmal genes containing different site-directed mutations were 
placed under control of the galactose-inducible promoter by subclon-
ing either an EcoRV-BstEU fragment (D143N^S234A mutations) 
into the plasmid pSN107 [13] or an BstEII-Hindlll fragment 
(R271T^T918A mutations) into the pRS427 [18]. All ATPase gene 
fragments containing the mutations were liberated from the corre-
sponding pmal genes cloned into the plasmid pUC18. The construc-
tion of these pmal alíeles has been described [4-7]. All the pmal alíeles 
used in this study were re-sequenced to ensure that only the desired 
mutation was present. The plasmids pSN107 and pRS427 are deriva-
tives of the URA3 single-copy plasmid YCp50 and contain the entire 
PMAI gene joined to a galactose-inducible promoter. Both plasmids 
are identical except that the URA3 gene of pSN107 was deleted and 
replaced by a new URA3 gene lacking its EcoRW site and inserted into 
the 3' end of GALlwPMAl [13]. This modification facilitated sub-
cloning of the £coRV-ßs/EII fragment of the mutant alíeles. After the 
dominant lethality test, each plasmid was rescued from yeast and its 
corresponding pmal alelle sequenced to confirm the presence of the 
mutation. Plasmid pFP239 is a derivative of the LEU2 single-copy 
plasmid pSB32 [19] and expresses an HA-tagged wild-type PMAI 
under the control of the galactose-inducible promoter. The nine-ami-
no-acid hemagglutinin (HA) epitope was introduced after the second 
amino acid of the ATPase by site-directed mutagenesis (F. Portillo, 
unpublished data). This insertion has no deleterious effects on func-
tion [13] or regulation (F. Portillo, unpublished data) of the ATPase. 
2.3. Fluorescence microscopy 
Strain W303 was transformed with pFP239 and either pSN107 or 
pRS427 derivatives containing different dominant lethal mutations. 
The transformants were selected in SD medium. To induce expression 
of GAL1::pmal genes, cells were cultured in SL medium overnight at 
30°C, collected, resuspended in SG medium and cultured for 5 h at 
30°C. Cells were fixed and stained for immunofluorescence as de-
scribed [20]. Localization of HA-tagged Pmal was determined by 
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immunofluorescence using a rhodamine-conjugated anti-HA antibody 
(Boehringer-Mannheim, Mannheim, Germany). 
3. Results 
3.1. Galactose-dependent lethality ofpmal mutations 
A direct demonstration of the dominant lethal effect of 
several pmal mutations was obtained by transforming a 
wild-type strain with a centromeric plasmid carrying the mu-
tant ATPase genes under the control of the GAL1 promoter. 
Under these conditions, cells carrying a dominant negative 
alíele arrest growth when they are transferred from glucose-
to galactose-containing medium. An example of the growth 
pattern of yeast strains carrying representative dominant le-
thal alíeles under the control of the galactose-inducible pro-
motor is shown in Fig. 1. The results of this test for dominant 
lethality, together with the previously described phenotype for 
a number of different in vitro-generated mutations [4-8], are 
presented in Table 1. The pmal-D378N and -K379Q genes 
were described previously as dominant negative [12,13] and 
were included in this study as controls. All the 12 dominant 
negative alíele genes identified in this work continued to ex-
hibit dominant lethality when the wild-type gene was also 
expressed from the GAL promotor (data not shown), suggest-
ing that lethality is not dose-dependent. It is interesting to 
note that, as expected, some dominant negative alíeles 
(pmal-D143N, -R271T, -C376L and -D378N genes) exhibited 
a wild-type phenotype in the constitutive expression system, 
confirming that lethal mutations were lost by gene conversion. 
However, most lethal alíeles exhibited either a recessive lethal 
(pmal-D200N, -E233Q, -P335A, -D378E, -D378T and -D638N 
genes) or recessive mutant (pmal -K379Q, and -K474R genes) 
phenotype when constitutively expressed. This suggests that 
dominant lethality, as well as being lost by gene conversion, 
can also be suppressed by second-site mutations. In fact, sec-
Table 1 
Dominant lethality oí pmal genes 
pmal genes 
E129Q 
D143N 
D200N 
D226N 
T231G 
E233Q 
S234A 
R271T 
P335A 
C376L 
D378N 
D378T 
D378E 
K379Q 
K474R 
K474H 
K474Q 
D638N 
N848D 
Q908E 
R909I 
S911A 
S911A/T912A 
T912A 
T918A 
Reported phenotype" 
wild type 
wild type 
recessive lethal 
recessive mutant 
recessive mutant 
recessive lethal 
recessive mutant 
wild type 
recessive lethal 
wild type 
wild type 
recessive lethal 
recessive lethal 
recessive mutant 
recessive mutant 
recessive mutant 
recessive lethal 
recessive lethal 
wild type 
wild type 
recessive mutant 
wild type 
recessive lethal 
recessive mutant 
wild type 
Dominant lethality 
-
+ 
+ 
— 
— 
+ 
— 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
— 
-
+ 
-
-
— 
-
— 
— 
-
aData are from references [4,i 
Fig. 1. Drop test for growth of yeast strains expressing dominant le-
thal alíeles of PMA1. Strains are recombinant, carrying the PMA1 
wild-type alíele or the indicated pmal gene under the control of the 
galactose-inducible promotor. The test was performed as indicated 
in Section 2. Plates were photographed after 36 h at 30°C. 
ond-site suppressor of the K474R dominant lethal alíele have 
been recently obtained [21] which constitutes a direct evidence 
for this mechanism. It remains to be explained why some 
dominant lethal mutations are suppressed by gene conversion, 
while others are suppressed by secondary mutations. 
3.2. Dominant lethal mutations interfere with the targeting of 
wild-type Pmal 
With multimeric proteins, as may be the yeast ATPase [22], 
a mutant protein might be dominant negative by creating, in 
association with the wild-type protein, an inactive or unregu-
lated oligomeric complex unable to perform its function. This 
would lead to lethality, since ATPase function is essential. 
Another possibility is that the mutant protein might interfere 
with wild-type protein transport to the membrane, decreasing 
the amount of correctly localized essential protein and arrest-
ing cell growth. This latter possibility has been recently shown 
to be true for several dominant negative Pmal mutants whose 
expression results in the trapping of the wild-type protein in 
subplasma membrane structures which also contain the endo-
plasmic reticulum marker protein Kar2 [23]. 
To test whether the dominant lethal alíeles identified here 
also interfered with wild-type Pmal targeting to the plasma 
membrane, we have investigated the transport of wild-type 
ATPase to the cell surface when dominant negative alíeles 
are also expressed. To this end, we introduced the HA epitope 
in the N-terminus of the wild-type Pmal protein and both the 
HA-tagged and dominant lethal genes were co-expressed 
under the control of the GAL1 promotor in the same cell. 
The location of the wild-type HA-tagged protein was studied 
in galactose-cultured cells by immunofluorescent staining of 
wild-type Pmal with the anti-HA monoclonal antibody (Fig. 
2). When HA-tagged wild-type protein was induced simulta-
neously with a dominant lethal protein, the anti-HA antibody 
decorated a set of cytoplasmic structures identical to those 
observed for other dominant negative Pmal proteins [13]. 
These cytoplasmic dots were not observed when the HA-
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Fig. 2. Accumulation of wild-type HA-tagged Pmal in cells expressing dominant lethal alíeles. Transformants carried the HA-tagged PMAl 
gene and either the wild-type or the indicated dominant lethal alíele under the control of the galactose-inducible promotor. Expression of the 
GAL::pmal genes was induced with galactose for 5 h. Panels show staining of the nucleus (DAPI) or immunofluorescence using a rhodamine-
conjugated anti-HA antibody (Anti-HA Ab). 
tagged gene was induced simultaneous with a wild-type pro-
tein. When only an HA-tagged dominant negative Pmal pro-
tein was expressed in the cell, the same staining of cytoplasmic 
dots was also observed (data not shown). These results sug-
gest that the dominant lethality of all 12 pmal alíeles exam-
ined is due to the interference of the mutant proteins with 
wild-type Pmal transport which results in the entrapment of 
the wild-type protein in some part of the secretory apparatus. 
4. Discussion 
Using site-directed mutagenesis in combination with a con-
stitutive expression system of the mutants [4—8], a specific role 
for several amino acids in the catalysis and regulation of the 
H+-ATPase had previously been assigned. In the light of the 
findings described here, the specific role of Asp-143, Arg-271, 
Glu-233, Cys-376 and Asp-638 residues in the the proposed 
model of structure-function of the ATPase [8] must be recon-
sidered. 
Amino acids Asp-143 and Arg-271 were described as non-
essential for ATPase as D143N and R271T mutations had no 
noticeable effect on ATPase activity [4,5]. Nevertheless, the 
fact that D143N and R271T mutations are here shown to 
be dominant lethal alíeles suggests that Asp-143 and Arg-
271 residues could be essential for the enzyme. 
With respect to Cys-376, the fact that the C376L mutation 
results in a dominant negative protein suggests that this res-
idue is essential for the enzyme. Nevertheless, the recent re-
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Fig. 3. Location of H+-ATPase mutants displaying dominant lethality. Phosphorylation site (Asp-378) and positions of the dominant lethal mu-
tations found in this work are indicated within the proposed structural topography of the H+-ATPase as determined from hydropathy analysis 
[6,26]. 
port by Petrov and Slayman [24] that Cys-376 can be replaced 
by Ala with no significant loss of activity indicates that Cys-
376 is not required for enzyme activity. An explanation for 
these results may be that the introduction of the more bulky 
Leu residue adjacent to Asp-378 could interfere, due to a 
steric effect, with the formation of the phosphorylated inter-
mediate and result, as for the D378N mutation, in a dominant 
negative protein. 
The Glu-233 residue was proposed to form part of a phos-
phatase domain, as the E233Q mutation blocked hydrolysis of 
the phosphorylated intermediate [4]. Amino acid Asp-638 was 
suggested to be involved in ATP binding to the adenine ring 
since the D638N mutation altered the enzyme's nucleotide 
hydrolysis specificity [4]. The fact that E233Q and D638N 
mutations result in dominant negative proteins suggests that 
these two amino acids must be important for enzyme function 
although a specific role cannot be assigned. 
Concerning to the non-dominant lethal mutations described 
in this study (E129Q, D226N, T231G, S234A, K474H, 
K474Q, N848D, Q908E, R909I, S911A, S911A/T912A, 
T912A and T918A) it cannot be completely discarded that 
the previously described phenotype obtained using the con-
stitutive expression system results from gene conversion or 
reversion. Because a functional H+-pump is essential, there 
is strong selective pressure for the accumulation of revertants 
during growth of cells harboring variants with low activity. 
Work in progress using an alternative expression system will 
help to elucidate the phenotype of the non-dominant lethal 
mutations described here. 
To date, dominant lethal mutations have been restricted to 
the phosphorylation site, to the first two putative transmem-
brane helices of the ATPase [12,13] and to the fifth putative 
membrane span [25]. Six of the dominant mutations described 
here were found to be located in three new regions of the 
enzyme (Fig. 3): three (D200N, E233Q and R271T mutations) 
in the small hydrophilic loop between hypothetical membrane 
segments 2 and 3, an additional two (K474R and D638N 
mutations) within the predicted nucleotide binding loop and 
the last (P335A mutation) in the putative fourth transmem-
brane helix. 
Futher work involving isolation of second-site suppressor 
mutations will help to understand the mechanism of dominant 
lethality exhibited by the pmal alíele described here and will 
allow assignation of a specific role for the essential residues. 
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